Metabolon,  Inc., is the global leader in revealing new biological insights through  metabolomics, harnessing the power of its Precision Metabolomics™ Platform to  provide biological insights of disease state and physiological reactions in  the present time. The company offers scalable, customizable metabolomics  solutions from discovery through clinical trials and product life-cycle  management. Leveraging one of the world’s most diverse and rich patient data  sets, Metabolon is equipped to deliver biologically relevant insights to  address some of the most difficult and pressing questions in the life  sciences, helping to accelerate research and product development success in  the biopharma, population health, consumer products, wellness and academic  research sectors.

Deal Source
Meghan M. McGee
Board Representative
No items found.
Associated Members
No items found.
No items found.